CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Tumour metastasis, the spread of cancer cells, is the leading cause of cancer mortality.
• The mechanisms driving breast cancer metastasis, particularly in triple-negative breast cancer, are not fully understood.
• Targeting metastasis is crucial for improving patient outcomes in breast cancer treatment.

Purpose of the Study:

• To investigate the role of CDK4/6 inhibition in blocking breast tumour metastasis.
• To elucidate the molecular mechanisms by which CDK4/6 influences metastasis.
• To identify potential therapeutic targets for preventing breast cancer spread.

Main Methods:

• Utilized a triple-negative breast cancer model to study tumour metastasis.
• Assessed the effect of CDK4/6 inhibition on tumour growth and metastasis.
• Investigated the interaction between CDK4/6, DUB3, and SNAIL1 using molecular assays.

Main Results:

• CDK4/6 inhibition effectively blocked breast tumour metastasis without impacting primary tumour growth.
• Identified DUB3 (a deubiquitinase) as a direct target of CDK4/6.
• Demonstrated that CDK4/6-activated DUB3 stabilizes SNAIL1, a key protein in epithelial-mesenchymal transition and metastasis.

Conclusions:

• The CDK4/6-DUB3 signaling axis is a critical regulator of breast cancer metastasis.
• Targeting this axis presents a promising therapeutic strategy for combating breast cancer metastasis.
• Findings provide a rationale for developing novel treatments to prevent cancer cell spread.